NEW YORK, March 22 (GenomeWeb News) - Abbott has granted Ikonisys a worldwide license to manufacture and sell DNA probes for its Chromotest, a prenatal diagnostic for chromosomal abnormalities, the companies said today.
Ikonisys also obtained from Abbott rights to buy chromosome fluorescence in situ hybridization probes in the fields of pre-implantation genetic diagnosis and automated detection in amniocytes of FISH signals of "the most common chromosomal abnormalities."
Terms of the first agreement call for Ikonisys to pay Abbott an upfront, non-refundable license fee and royalties on commercialized kits. Terms of the second agreement were undisclosed. Ikonisys is based in